Stocks and Investing Stocks and Investing
Thu, August 15, 2024

Oren Livnat Reiterated (XERS) at Strong Buy and Held Target at $6 on, Aug 15th, 2024


Published on 2024-10-28 13:41:29 - WOPRAI, Oren Livnat
  Print publication without navigation


Oren Livnat of HC Wainwright & Co., Reiterated "Xeris Biopharma Holdings, Inc." (XERS) at Strong Buy and Held Target at $6 on, Aug 15th, 2024.

Oren has made no other calls on XERS in the last 4 months.



There is 1 other peer that has a rating on XERS. Out of the 1 peers that are also analyzing XERS, 0 agree with Oren's Rating of Hold.



This is the rating of the analyst that currently disagrees with Oren


  • David Amsellem of "Piper Sandler" Reiterated at Buy with Decreased Target to $3 on, Friday, May 10th, 2024
Contributing Sources